Your browser doesn't support javascript.
loading
Application of Radiomics in Predicting Treatment Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: Strategies and Challenges.
Chen, Rui; Fu, Yan; Yi, Xiaoping; Pei, Qian; Zai, Hongyan; Chen, Bihong T.
Afiliação
  • Chen R; Department of Radiology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
  • Fu Y; Department of Radiology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
  • Yi X; Department of Radiology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
  • Pei Q; Department of Radiology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
  • Zai H; Department of Radiology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
  • Chen BT; Department of Diagnostic Radiology, City of Hope National Medical Center, Duarte, CA, USA.
J Oncol ; 2022: 1590620, 2022.
Article em En | MEDLINE | ID: mdl-36471884
ABSTRACT
Neoadjuvant chemoradiotherapy (nCRT) followed by total mesorectal excision is the standard treatment for locally advanced rectal cancer (LARC). A noninvasive preoperative prediction method should greatly assist in the evaluation of response to nCRT and for the development of a personalized strategy for patients with LARC. Assessment of nCRT relies on imaging and radiomics can extract valuable quantitative data from medical images. In this review, we examined the status of radiomic application for assessing response to nCRT in patients with LARC and indicated a potential direction for future research.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China